BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12511595)

  • 1. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis.
    Sohn J; Kim TI; Yoon YH; Kim JY; Kim SY
    J Clin Invest; 2003 Jan; 111(1):121-8. PubMed ID: 12511595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I.
    Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
    Nature; 1988 Oct; 335(6192):726-30. PubMed ID: 2971881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase.
    Moreno JJ
    Int Immunopharmacol; 2006 Feb; 6(2):300-3. PubMed ID: 16399636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications of antiflammin peptides in experimental ocular inflammation.
    Chan CC; Tuaillon N; Li Q; Shen DF
    Ann N Y Acad Sci; 2000; 923():141-6. PubMed ID: 11193752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.
    Kim DS; Park KS; Jeong KC; Lee BI; Lee CH; Kim SY
    Cancer Lett; 2009 Jan; 273(2):243-9. PubMed ID: 18804908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New target against inflammatory diseases: transglutaminase 2.
    Kim SY
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):332-7. PubMed ID: 15507874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Peptide with anti-transglutaminase activity decreases lipopolysaccharide-induced lung inflammation in mice.
    Suh GY; Ham HS; Lee SH; Choi JC; Koh WJ; Kim SY; Lee J; Han J; Kim HP; Choi AM; Kwon OJ
    Exp Lung Res; 2006; 32(1-2):43-53. PubMed ID: 16809220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DP2 (CRTh2) antagonism reduces ocular inflammation induced by allergen challenge and respiratory syncytial virus.
    Stebbins KJ; Broadhead AR; Musiyenko A; Barik S; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
    Int Arch Allergy Immunol; 2012; 157(3):259-68. PubMed ID: 22042170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.
    Jeong KC; Ahn KO; Lee BI; Lee CH; Kim SY
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):143-50. PubMed ID: 19655169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase 2 induces nitric oxide synthesis in BV-2 microglia.
    Park KC; Chung KC; Kim YS; Lee J; Joh TH; Kim SY
    Biochem Biophys Res Commun; 2004 Oct; 323(3):1055-62. PubMed ID: 15381106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
    Case A; Stein RL
    Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of peptidic maleimides as transglutaminase inhibitors.
    Halim D; Caron K; Keillor JW
    Bioorg Med Chem Lett; 2007 Jan; 17(2):305-8. PubMed ID: 17092716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
    Tetta C; Camussi G; Bussolino F; Herrick-Davis K; Baglioni C
    J Pharmacol Exp Ther; 1991 May; 257(2):616-20. PubMed ID: 2033508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid beta-peptide.
    Zhang W; Johnson BR; Bjornsson TD
    Life Sci; 1997; 60(25):2323-32. PubMed ID: 9194688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of novel dipeptide-bound 1,2,4-thiadiazoles as irreversible inhibitors of guinea pig liver transglutaminase.
    Marrano C; de Macédo P; Gagnon P; Lapierre D; Gravel C; Keillor JW
    Bioorg Med Chem; 2001 Dec; 9(12):3231-41. PubMed ID: 11711299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding to PLA2 may contribute to the anti-inflammatory activity of catechol.
    Dileep KV; Tintu I; Mandal PK; Karthe P; Haridas M; Sadasivan C
    Chem Biol Drug Des; 2012 Jan; 79(1):143-7. PubMed ID: 21995306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel transglutaminase inhibitors reduce the cornified cell envelope formation.
    Kim SY; Park WM; Jung SW; Lee J
    Biochem Biophys Res Commun; 1997 Apr; 233(1):39-44. PubMed ID: 9144392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiflammins: endogenous nonapeptides with regulatory effect on inflammation.
    Moreno JJ
    Gen Pharmacol; 1997 Jan; 28(1):23-6. PubMed ID: 9112072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship study of novel tissue transglutaminase inhibitors.
    Duval E; Case A; Stein RL; Cuny GD
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1885-9. PubMed ID: 15780627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of transglutaminase in the activation of latent transforming growth factor beta1 in aging articular cartilage.
    Rosenthal AK; Gohr CM; Henry LA; Le M
    Arthritis Rheum; 2000 Aug; 43(8):1729-33. PubMed ID: 10943862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.